Literature DB >> 19050303

Ligand-dependent and -independent regulation of PPAR gamma and orphan nuclear receptors.

H Eric Xu1, Yong Li.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPAR gamma) is considered to be a ligand-activated nuclear receptor with essential roles in adipogenesis, glucose and lipid homeostasis, and inflammatory responses. An unusually large ligand-binding pocket is a distinguishing feature of PPAR gamma and two related receptors, PPAR alpha and PPAR beta (also known as PPAR delta), which allows these receptors to interact with diverse chemical ligands including various fatty acids, fibrates, and the thiazolidinedione class of antidiabetic drugs. However, the physiologically relevant ligand of PPARs remains unknown. A PPAR gamma mutant that is incapable of binding ligands unexpectedly directed adipogenesis when introduced into fibroblasts. This raises key issues regarding the existence and roles of the hypothetical physiological ligands for PPAR gamma, issues that may also apply to other "orphan" nuclear receptors lacking bona fide ligands. Identification of the physiological ligands of PPARs and orphan nuclear receptors will be crucial for understanding the biology of these receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050303     DOI: 10.1126/scisignal.148pe52

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  11 in total

Review 1.  Peroxisomes: a nexus for lipid metabolism and cellular signaling.

Authors:  Irfan J Lodhi; Clay F Semenkovich
Journal:  Cell Metab       Date:  2014-02-06       Impact factor: 27.287

2.  Couple dynamics: PPARγ and its ligand partners.

Authors:  Shanghai Yu; H Eric Xu
Journal:  Structure       Date:  2012-01-11       Impact factor: 5.006

3.  ω-6 lipids regulate PPAR turnover via reciprocal switch between PGC-1 alpha and ubiquitination.

Authors:  Jia Fei; Carla Cook; Nalini Santanam
Journal:  Atherosclerosis       Date:  2012-03-14       Impact factor: 5.162

4.  Relaxin signaling activates peroxisome proliferator-activated receptor gamma.

Authors:  Sudhir Singh; Robert G Bennett
Journal:  Mol Cell Endocrinol       Date:  2009-08-25       Impact factor: 4.102

Review 5.  Adipocytes under assault: environmental disruption of adipose physiology.

Authors:  Shane M Regnier; Robert M Sargis
Journal:  Biochim Biophys Acta       Date:  2013-06-02

6.  Caspase 2 activation and ER stress drive rapid Jurkat cell apoptosis by clofibrate.

Authors:  Fabio Penna; Fabrizio Pin; Domiziana Costamagna; Patrizia Reffo; Francesco Maria Baccino; Gabriella Bonelli; Paola Costelli
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  A Comparative Study of Mouse Hepatic and Intestinal Gene Expression Profiles under PPARα Knockout by Gene Set Enrichment Analysis.

Authors:  Kan He; Qishan Wang; Yumei Yang; Minghui Wang; Yuchun Pan
Journal:  PPAR Res       Date:  2011-07-27       Impact factor: 4.964

8.  Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.

Authors:  Marcelo Vizoná Liberato; Alessandro S Nascimento; Steven D Ayers; Jean Z Lin; Aleksandra Cvoro; Rodrigo L Silveira; Leandro Martínez; Paulo C T Souza; Daniel Saidemberg; Tuo Deng; Angela Angelica Amato; Marie Togashi; Willa A Hsueh; Kevin Phillips; Mário Sérgio Palma; Francisco A R Neves; Munir S Skaf; Paul Webb; Igor Polikarpov
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

9.  Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency.

Authors:  Weili Zheng; Lin Qiu; Rui Wang; Xuhui Feng; Yaping Han; Yanlin Zhu; Dezhou Chen; Yijie Liu; Lihua Jin; Yong Li
Journal:  Sci Rep       Date:  2015-07-17       Impact factor: 4.379

10.  A microfluidic, high throughput protein crystal growth method for microgravity.

Authors:  Carl W Carruthers; Cory Gerdts; Michael D Johnson; Paul Webb
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.